Crescita Therapeutics (Crescita Therapeutics) EV-to-Revenue

: 0.02 (As of Today)

View and export this data going back to 2016. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Crescita Therapeutics's enterprise value is $0.20 Mil. Crescita Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $13.01 Mil. Therefore, Crescita Therapeutics's EV-to-Revenue for today is 0.02.

The historical rank and industry rank for Crescita Therapeutics's EV-to-Revenue or its related term are showing as below:

CRRTF' s EV-to-Revenue Range Over the Past 10 Years
Min: -51.75 Med: 0.32 Max: 25.93
Current: 0.02

During the past 10 years, the highest EV-to-Revenue of Crescita Therapeutics was 25.93. The lowest was -51.75. And the median was 0.32.

CRRTF's EV-to-Revenue is ranked better than
98.44% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.28 vs CRRTF: 0.02

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-24), Crescita Therapeutics's stock price is $0.32. Crescita Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.64. Therefore, Crescita Therapeutics's PS Ratio for today is 0.50.

Crescita Therapeutics EV-to-Revenue Historical Data

The historical data trend for Crescita Therapeutics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

0.52

0.09

0.31

0.29

0.09

Crescita Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.29	0.19	0.20	0.21	0.09

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Crescita Therapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescita Therapeutics EV-to-Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Crescita Therapeutics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Crescita Therapeutics's EV-to-Revenue falls into.

Crescita Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Crescita Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	0.197	/	13.012
	=	0.02

Crescita Therapeutics's current Enterprise Value is $0.20 Mil.
Crescita Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.01 Mil.

Crescita Therapeutics (OTCPK:CRRTF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Crescita Therapeutics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.32	/	0.642
	=	0.50

Crescita Therapeutics's share price for today is $0.32.
Crescita Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.64.

Crescita Therapeutics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (Crescita Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (OTCPK:CRRTF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

CTX:Canada

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.